Cargando…
High-risk Combinations of Additional Chromosomal Abnormalities in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia: JALSG Ph+ALL TKI-SCT Study
Autores principales: | Nishiwaki, Satoshi, Sugiura, Isamu, Fujisawa, Shin, Hatta, Yoshihiro, Atsuta, Yoshiko, Doki, Noriko, Kurahashi, Shingo, Ueda, Yasunori, Dobashi, Nobuaki, Maeda, Tomoya, Taniguchi, Yasuhiro, Tanaka, Masatsugu, Kako, Shinichi, Ichinohe, Tatsuo, Fukuda, Takahiro, Ohtake, Shigeki, Ishikawa, Yuichi, Kiyoi, Hitoshi, Matsumura, Itaru, Miyazaki, Yasushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356120/ https://www.ncbi.nlm.nih.gov/pubmed/37475881 http://dx.doi.org/10.1097/HS9.0000000000000899 |
Ejemplares similares
-
Dasatinib-based 2-step induction for adults with Philadelphia chromosome–positive acute lymphoblastic leukemia
por: Sugiura, Isamu, et al.
Publicado: (2022) -
Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph+ALL
por: Hatta, Yoshihiro, et al.
Publicado: (2018) -
Machine learning-aided risk stratification in Philadelphia chromosome-positive acute lymphoblastic leukemia
por: Nishiwaki, Satoshi, et al.
Publicado: (2021) -
Allogeneic hematopoietic stem cell transplantation at the first remission for younger adults with FLT3‐internal tandem duplication AML: The JALSG AML209‐FLT3‐SCT study
por: Kawashima, Naomi, et al.
Publicado: (2020) -
Tyrosine kinase inhibitor prophylaxis after transplant for Philadelphia chromosome‐positive acute lymphoblastic leukemia
por: Akahoshi, Yu, et al.
Publicado: (2019)